![]() 1010 Wins | Pfizer shares at risk following heart-drug failure Reuters - By Ransdell Pierson. NEW YORK (Reuters) - With the sudden failure of torcetrapib Pfizer Inc.'s most important experimental product financial analysts predict shares of the world's largest drugmaker could ... Key drug's failure imperils Pfizer Pfizer Stops Developing Cholesterol Drug |